Array BioPharma Shareholders Equity:
-31.72M for Dec. 31, 2012Array BioPharma Historical Shareholders Equity Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -31.72M |
| Sept. 30, 2012 | -96.42M |
| June 30, 2012 | -85.81M |
| March 31, 2012 | -78.77M |
| Dec. 31, 2011 | -127.19M |
| Sept. 30, 2011 | -133.84M |
| June 30, 2011 | -130.86M |
| March 31, 2011 | -144.15M |
| Dec. 31, 2010 | -130.64M |
| Sept. 30, 2010 | -125.23M |
| June 30, 2010 | -116.68M |
| March 31, 2010 | -109.49M |
| Dec. 31, 2009 | -97.59M |
| Sept. 30, 2009 | -82.52M |
| June 30, 2009 | -73.70M |
| March 31, 2009 | -54.96M |
| Dec. 31, 2008 | -26.98M |
| Sept. 30, 2008 | 8.046M |
| June 30, 2008 | 38.03M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
About Shareholders' Equity
Shareholders' equity is difference between a company's total assets and total liabilities. Also referred to as stockholders' equity, net worth, or net assets.
Learn More
ARRY Shareholders Equity Benchmarks
| Companies | |
|---|---|
| Celldex Therapeutics | 194.94M |
| Cytokinetics | 58.43M |
| Ariad Pharmaceuticals | 363.98M |
ARRY Shareholders Equity Rankings
| Overall |
33rd percentile 5342 of 8005 |
| Sector |
9th percentile 624 of 686 in Healthcare |
| Industry |
11th percentile 220 of 248 in Biotechnology |
ARRY Shareholders Equity Range, Past 5 Years
| Minimum | -144.15M | Mar 2011 |
| Maximum | 38.03M | Jun 2008 |
| Average | -84.24M |
